Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04753203
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-10-31
First Post:
2021-02-04
Brief Title:
Alpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients
Sponsor:
Korean Cancer Study Group
Organization:
Korean Cancer Study Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-04
First Submit QC Date:
February 11 2021
Study First Post Date:
2021-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-29
Last Update Post Date:
2023-10-31
Last Update Post Date Type:
ACTUAL